Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'VIII' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2696 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Smales, CM; Pepper, DS; James, DC
      Protein modifications during antiviral heat bioprocessing and subsequent storage

      BIOTECHNOLOGY PROGRESS
    2. Chang, TJ; Mohamed, S; Hambleton, J
      Hemophilic arthropathy: Considerations in management

      JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
    3. Chao, HJ; Monahan, PE; Liu, YB; Samulski, RJ; Walsh, CE
      Sustained and complete phenotype correction of hemophilia B mice followingintramuscular injection of AAV1 serotype vectors

      MOLECULAR THERAPY
    4. McCormack, JE; Edwards, W; Sensintaffer, J; Lillegren, L; Kozloski, M; Brumm, D; Karavodin, L; Jolly, DJ; Greengard, J
      Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector

      MOLECULAR THERAPY
    5. Lipshutz, GS; Gruber, CA; Cao, YA; Hardy, J; Contag, CH; Gaensler, KML
      In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression

      MOLECULAR THERAPY
    6. de Wit, TR; van Mourik, JA
      Biosynthesis, processing and secretion of von Willebrand factor: biological implications

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Ruggeri, ZM
      Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Schneppenheim, R; Budde, U; Ruggeri, ZM
      A molecular approach to the classification of von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    9. Favaloro, EJ
      Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    10. Rodeghiero, F; Castaman, G
      Congenital von Willebrand disease type I: definition, phenotypes, clinicaland laboratory assessment

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    11. Mazurier, C; Goudemand, J; Hilbert, L; Caron, C; Fressinaud, E; Meyer, D
      Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    12. Eikenboom, JCJ
      Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    13. Michiels, JJ; Budde, U; van der Planken, M; van Vliet, HHDM; Schroyens, W; Berneman, Z
      Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    14. Mannucci, PM; Federici, AB
      Management of inherited von Willebrand disease

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    15. Emanuel, BS; Shaikh, TH
      Segmental duplications: An 'expanding' role in genomic instability and disease

      NATURE REVIEWS GENETICS
    16. Kohl, I; Mayer, E; Hallbrucker, A
      Ice XII forms on compression of hexagonal ice at 77 K via high-density amorphous water

      PHYSICAL CHEMISTRY CHEMICAL PHYSICS
    17. Schmaldienst, S; Mullner, M; Goldammer, A; Spitzauer, S; Banyai, S; Horl, WH; Derfler, K
      Intravenous immunoglobulin application following immunoadsorption: benefitor risk in patients with autoimmune diseases?

      RHEUMATOLOGY
    18. Straka, M; Dyall, KG; Pyykko, P
      Ab initio study of bonding trends for f(0) actinide oxyfluoride species

      THEORETICAL CHEMISTRY ACCOUNTS
    19. Illert, WE; Butsch, H; Nuber, D; Howe, J; Sanger, W; Weidinger, S
      Long-term storage multicenter study of fresh frozen plasma at -40 degrees C. A multicenter study on the stability of labile coagulation factors over a period of 3 years

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    20. Grimm, DR; Colter, MB; Braunschweig, M; Alexander, LJ; Neame, PJ; Kim, HKW
      Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains

      CELLULAR AND MOLECULAR LIFE SCIENCES
    21. Josic, D; Buchacher, A; Jungbauer, A
      Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion

      JOURNAL OF CHROMATOGRAPHY B
    22. Pflegerl, K; Hahn, R; Schallaun, E; Josic, D; Jungbauer, A
      Quantification of plasma-derived blood coagulation factor VIII by real-time biosensor measurements

      JOURNAL OF CHROMATOGRAPHY B
    23. Illidge, C; Kielty, C; Shuttleworth, A
      Type VIII collagen: heterotrimeric chain association

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    24. Liras, A
      Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?

      HAEMOPHILIA
    25. Fischer, K; Van der Bom, JG; Mauser-Bunschoten, EP; Roosendaal, G; Prejs, R; Grobbee, DE; Van den Berg, HM
      Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

      HAEMOPHILIA
    26. Miners, AH; Sabin, CA; Tolley, KH; Parnaby, A; Lee, CA
      Assessing the relationship between productivity levels and severity of haemophilia

      HAEMOPHILIA
    27. Timur, AA; Gurgey, A; Aktuglu, G; Kavakli, K; Canatan, D; Olek, K; Caglayan, SH
      Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations

      HAEMOPHILIA
    28. Zanon, E; Vianello, F; Casonato, A; Girolami, A
      Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease

      HAEMOPHILIA
    29. Meiklejohn, DJ; Watson, HG
      Acquired haemophilia in association with organ-specific autoimmune disease

      HAEMOPHILIA
    30. Makris, M; Baglin, T; Dusheiko, G; Giangrande, PLF; Lee, CA; Ludlam, CA; Preston, FE; Watson, HG; Wilde, JT; Winter, M
      Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia

      HAEMOPHILIA
    31. Scharrer, I; Ehrlich, HJ
      Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII

      HAEMOPHILIA
    32. Rizza, CR; Hill, FGH; Spooner, RJD; Giangrande, PLF
      Treatment of haemophilia in the United Kingdom 1981-1996

      HAEMOPHILIA
    33. Berntorp, E; Petrini, P; Dockter, G; Tengborn, L; Wendisch, I; Eberl, W; Aumann, V; Frade, G; Seliger, I; Engl, W; Ehrlich, H
      An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients

      HAEMOPHILIA
    34. Mauser-Bunschoten, EP; van der Bom, JG; Bongers, M; Twijnstra, M; Roosendaal, G; Fischer, K; van den Berg, HM
      Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A

      HAEMOPHILIA
    35. Kallas, A; Talpsep, T
      von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients

      HAEMOPHILIA
    36. Theophilus, BDM; Enayat, MS; Williams, MD; Hill, FGH
      Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A

      HAEMOPHILIA
    37. Acquila, M; Bottini, F; Valetto, A; Caprino, D; Mori, PG; Bicocchi, MP
      A new strategy for prenatal diagnosis in a sporadic haemophilia B family

      HAEMOPHILIA
    38. Mazzucconi, MG; Bizzoni, L; Giorgi, A; Morano, SG; Peraino, M; Russo, M; Alimena, G
      Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone

      HAEMOPHILIA
    39. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    40. Cohen, AJ; Kessler, CM; Ewenstein, BM
      Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America

      HAEMOPHILIA
    41. Yoshioka, A; Shima, M; Fukutake, K; Takamatsu, J; Shirahata, A
      Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

      HAEMOPHILIA
    42. Leissinger, C; Becton, D; Cornell, C; Gill, JC
      High-dose DDAVP intranasal spray (Stimate((R))) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

      HAEMOPHILIA
    43. Astermark, J; Berntorp, E; White, GC; Kroner, BL
      The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

      HAEMOPHILIA
    44. Ghosh, K; Shetty, S; Kulkarni, B; Nair, S; Pawar, A; Khare, A; Baindur, S; Mohanty, D
      Development of inhibitors in patients with haemophilia from India

      HAEMOPHILIA
    45. Klein, I; Andrikovics, H; Bors, A; Nemes, L; Tordai, A; Varadi, A
      A haemophilia A and B molecular genetic diagnostic programme in Hungary: ahighly informative and cost-effective strategy

      HAEMOPHILIA
    46. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    47. Kashyap, R; Choudhry, VP; Mahapatra, M; Chumber, S; Saxena, R; Kaul, HL
      Postpartum acquired haemophilia: clinical recognition and management

      HAEMOPHILIA
    48. Samaiya, A; Gupta, S; Chumber, S; Kashyap, R; Dewanda, NK; Vashisht, S; Choudhry, VP
      Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient

      HAEMOPHILIA
    49. Yenchitsomanus, P; Thanootarakul, P; Akkarapatumwong, V; Oranwiroon, S; Pung-Amritt, P; Veerakul, G; Mahasandana, C
      Mutation causing exon 15 skipping and partial exon 16 deletion in factor VIII transcript, and a method for direct mutation detection

      HAEMOPHILIA
    50. Bjorkman, S; Shapiro, AD; Berntorp, E
      Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

      HAEMOPHILIA
    51. Haya, S; Lopez, MF; Aznar, JA; Batlle, J
      Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

      HAEMOPHILIA
    52. Dykes, AC; Walker, ID; Lowe, GDO; Tait, RC
      Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review

      HAEMOPHILIA
    53. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
      Acquired haemophilia: experiences with a standardized approach

      HAEMOPHILIA
    54. Soucie, JM; Symons, J; Evatt, B; Brettler, D; Huszti, H; Linden, J
      Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

      HAEMOPHILIA
    55. Mondorf, W; Klinge, J; Luban, NLC; Bray, G; Saenko, E; Scandella, D
      Low factor VIII recovery in haemophilia A patients without inhibitor titreis not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay

      HAEMOPHILIA
    56. Oranwiroon, S; Akkarapatumwong, V; Pung-Amritt, P; Treesucon, A; Veerakul, G; Mahasandana, C; Panyim, S; Yenchitsomanus, P
      Determination of haemophilia A carrier status by mutation analysis

      HAEMOPHILIA
    57. Klinge, J; Auerswald, G; Budde, U; Klose, H; Kreuz, W; Lenk, H; Scandella, D
      Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay

      HAEMOPHILIA
    58. Calvez, T; Biou, M; Costagliola, D; Jullien, AM; Laurian, Y; Rossi, F; Rothschild, C; Sie, P
      The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system

      HAEMOPHILIA
    59. Miller, R
      The responsibility of separating truth from myth to patient and family

      HAEMOPHILIA
    60. Mauser-Bunschoten, EP; Roosendaal, G; Van den Berg, HM
      Product choice and haemophilia treatment in the Netherlands

      HAEMOPHILIA
    61. Berntorp, E
      Immune tolerance induction: recombinant vs. human-derived product

      HAEMOPHILIA
    62. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    63. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    64. Ewenstein, BM
      Use of ristocetin cofactor activity in the management of von Willebrand disease

      HAEMOPHILIA
    65. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    66. Ragni, MV
      New-generation recombinant factor concentrates: bridge to gene therapy

      HAEMOPHILIA
    67. Alberth, G; Kettisen, J; Lisander, B
      Blood loss in prosthetic hip replacement is not influenced by the AB0 blood group

      EUROPEAN JOURNAL OF SURGERY
    68. Turgeman, G; Pittman, DD; Muller, R; Kurkalli, BG; Zhou, SH; Pelled, G; Peyser, A; Zilberman, Y; Moutsatsos, IK; Gazit, D
      Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

      JOURNAL OF GENE MEDICINE
    69. Sarukhan, A; Soudais, C; Danos, O; Jooss, K
      F;actors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors

      JOURNAL OF GENE MEDICINE
    70. Chuah, MKL; Collen, D; VandenDriessche, T
      Gene therapy for hemophilia

      JOURNAL OF GENE MEDICINE
    71. Kamphuisen, PW; Eikenboom, JCJ; Bertina, RM
      Elevated factor VIII levels and the risk of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    72. Schambeck, CM; Hinney, K; Haubitz, I; Taleghani, BM; Wahler, D; Keller, F
      Familial clustering of high factor VIII levels in patients with venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    73. Sumner, M; Suiter, T
      Accuracy about coagulation products

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    74. Shord, SS; Lindley, C
      Accuracy about coagulation products

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    75. Michiels, JJ; Schroyens, W; Berneman, Z; van der Planken, S
      Atypical variant of acquired von Willebrand syndrome in Wilms tumor: Is hyaluronic acid secreted by nephroblastoma cells the cause?

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    76. Michiels, JJ; Schroyens, W; van der Planken, M; Berneman, Z
      Acquired von Willebrand syndrome in systemic lupus erythematodes

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    77. Kagawa, H; Nomura, S; Nagahama, M; Ozaki, Y; Fukuhara, S
      Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    78. Cavazzana-Calvo, M; Hacein-Bey-Abina, S
      Correction of genetic blood defects by gene transfer

      CURRENT OPINION IN HEMATOLOGY
    79. Hambleton, J
      Diagnosis and incidence of inherited von Willebrand disease

      CURRENT OPINION IN HEMATOLOGY
    80. Sobolev, GA; Nikitin, AN
      Neutron diffraction analysis in geophysics

      PHYSICS OF PARTICLES AND NUCLEI
    81. Sleeman, JP; Krishnan, J; Kirkin, V; Baumann, P
      Markers for the lymphatic endothelium: In search of the holy grail?

      MICROSCOPY RESEARCH AND TECHNIQUE
    82. Witte, MH; Bernas, MJ; Martin, CP; Witte, CL
      Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology

      MICROSCOPY RESEARCH AND TECHNIQUE
    83. Dahm, T; White, J; Grill, S; Fullekrug, J; Stelzer, EHK
      Quantitative ER <-> Golgi transport kinetics and protein separation upon Golgi exit revealed by vesicular integral membrane protein 36 dynamics in live cells

      MOLECULAR BIOLOGY OF THE CELL
    84. Burggraaf, J; Lalezari, S; Emeis, JJ; Vischer, UM; de Meyer, PHEM; Pijl, H; Cohen, AF
      Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol

      THYROID
    85. Bristol, JA; Gallo-Penn, A; Andrews, J; Idamakanti, N; Kaleko, M; Connelly, S
      Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia a mice compared with factor VIII protein infusion

      HUMAN GENE THERAPY
    86. Tascou, S; Nayernia, K; Uedelhoven, J; Bohm, D; Jalal, R; Ahmed, M; Engel, W; Burfeind, P
      Isolation and characterization of differentially expressed genes in invasive and non-invasive immortalized murine male germ cells in vitro

      INTERNATIONAL JOURNAL OF ONCOLOGY
    87. Shetty, S; Ghosh, K; Bhide, A; Mohanty, D
      Carrier detection and prenatal diagnosis in families with haemophilia

      NATIONAL MEDICAL JOURNAL OF INDIA
    88. Fields, PA; Armstrong, E; Hagstrom, JN; Arruda, VR; Murphy, ML; Farrell, JP; High, KA; Herzog, RW
      Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice

      GENE THERAPY
    89. Aradhya, S; Bardaro, T; Galgoczy, P; Yamagata, T; Esposito, T; Patlan, H; Ciccodicola, A; Munnich, A; Kenwrick, S; Platzer, M; D'Urso, M; Nelson, DL
      Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes

      HUMAN MOLECULAR GENETICS
    90. Biswas, S; Munier, FL; Yardley, J; Hart-Holden, N; Perveen, R; Cousin, P; Sutphin, JE; Noble, B; Batterbury, M; Kielty, C; Hackett, A; Bonshek, R; Ridgway, A; McLeod, D; Sheffield, VC; Stone, EM; Schorderet, DF; Black, GCM
      Missense mutations in COL8A2, the gene encoding the alpha 2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy

      HUMAN MOLECULAR GENETICS
    91. Aradhya, S; Woffendin, H; Jakins, T; Bardaro, T; Esposito, T; Smahi, A; Shaw, C; Levy, M; Munnich, A; D'Urso, M; Lewis, RA; Kenwrick, S; Nelson, DL
      A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations

      HUMAN MOLECULAR GENETICS
    92. Meyer, DL; Schultz, J; Lin, YK; Henry, A; Sanderson, J; Jackson, JM; Goshorn, S; Rees, AR; Graves, SS
      Reduced antibody response to streptavidin through site-directed mutagenesis

      PROTEIN SCIENCE
    93. Gu, C; Sorkin, A; Cooper, DMF
      Persistent interactions between the two transmembrane clusters dictate thetargeting and functional assembly of adenylyl cyclase

      CURRENT BIOLOGY
    94. Sinha, S; Kielty, CM; Heagerty, AM; Canfield, AE; Shuttleworth, CA
      Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis

      INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
    95. Hornsey, VS; Drummond, O; Young, D; Docherty, A; Prowse, CV
      A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system

      TRANSFUSION MEDICINE
    96. Melton, LG; Li, T; Stafford, DW; Gabriel, DA
      Location of the platelet binding site in zymogen coagulation factor IX

      BLOOD COAGULATION & FIBRINOLYSIS
    97. Kramoroff, A; Nigretto, JM
      In vitro factor XI activation mechanism according to an optimized model ofactivated partial thromboplastin time test

      BLOOD COAGULATION & FIBRINOLYSIS
    98. Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ
      The impact of oral anticoagulant therapy, factor VIII level and quality offactor V-deficient plasma on three commercial methods for activated protein C resistance

      BLOOD COAGULATION & FIBRINOLYSIS
    99. Yngen, M; Ostenson, CG; Li, N; Hjemdahl, P; Wallen, NH
      Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus

      BLOOD COAGULATION & FIBRINOLYSIS
    100. Jenkins, S; Morrison, I
      The dependence on structure of the projected vibrational density of statesof various phases of ice as calculated by ab initio methods

      JOURNAL OF PHYSICS-CONDENSED MATTER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 16:48:47